Outlook Therapeutics Secures $5 Million in Public Offering

Outlook Therapeutics closed a $5 million public offering, selling 20 million shares of common stock and warrants to purchase up to 20 million shares. The gross proceeds were $5 million, with potential additional proceeds of $5 million if warrants are fully exercised. The company intends to use the funds for working capital and general corporate purposes.